当前位置:
X-MOL 学术
›
Nat. Biotechnol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
After Myriad, what makes a gene patent claim 'markedly different' from nature?
Nature Biotechnology ( IF 33.1 ) Pub Date : 2017-09-11 00:00:00 , DOI: 10.1038/nbt.3953 Mateo Aboy , Johnathon Liddicoat , Kathleen Liddell , Matthew Jordan , Cristina Crespo
Nature Biotechnology ( IF 33.1 ) Pub Date : 2017-09-11 00:00:00 , DOI: 10.1038/nbt.3953 Mateo Aboy , Johnathon Liddicoat , Kathleen Liddell , Matthew Jordan , Cristina Crespo
Examining the types of claim amendments that have transformed isolated gene claims from patent-ineligible into eligible subject matter provides clarity into the threshold of eligibility for gene-related patents.
中文翻译:
在无数之后,什么使基因专利主张与自然“显着不同”?
检查将已分离的基因权利要求从不符合专利权的条件转变为合格主题的权利要求修正的类型,可以清楚地了解与基因相关的专利的资格门槛。
更新日期:2017-09-12
中文翻译:
在无数之后,什么使基因专利主张与自然“显着不同”?
检查将已分离的基因权利要求从不符合专利权的条件转变为合格主题的权利要求修正的类型,可以清楚地了解与基因相关的专利的资格门槛。